Effect of stress related to the 9/11/2001 terror attack on seizures in patients with epilepsy
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Stress facilitates seizures in patients with epilepsy. The frequency with which this occurs is uncertain. Estimates range widely, from 14 to 67% of patients affected,1–5 mainly because there is no uniform definition of stress. One way of bypassing the problem of the definition of stress is to examine the effects on seizures of an event that is generally recognized as stressful. The 9/11/2001 terrorist attack was such an event in the United States. In the current study, we examined the effect of 9/11 attack-related emotional stress on seizures among patients with epilepsy in an area directly involved in one of the attacks, Washington, DC, by comparing seizure frequency before and after the attack. In addition, because we had studied the association of subjectively perceived stress with seizures in the same patients before 9/11, we compared the change in seizure frequency following 9/11 with patients' own assessment of stress as a seizure precipitant.
Methods.
Cognitively normal adult patients with epilepsy seen consecutively in the Georgetown University Hospital (GUH) Epilepsy Clinic between 9/12 and 12/20/01 were evaluated. GUH is 3 miles from the Pentagon, the Washington target of the 9/11/2001 attack. Greater Washington area residents present …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizuresV. Biton, J. C. Sackellares, A. Vuong et al.Neurology, December 12, 2005 -
Articles
Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 monthsJ. E. Piña-Garza, P. Levisohn, K. Gucuyener et al.Neurology, December 12, 2007 -
Articles
A double-blind, randomized trial of topiramate in Lennox–Gastaut syndromeR.C. Sachdeo, T.A. Glauser, F. Ritter et al.Neurology, June 01, 1999 -
Articles
A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizuresV. Biton, G.D. Montouris, F. Ritter et al.Neurology, April 01, 1999